R. Erik Holmlin's most recent trade in Bionano Genomics Inc was a trade of 75 Common Stock done at an average price of $3.7 . Disclosure was reported to the exchange on June 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Bionano Genomics Inc | R. Erik Holmlin | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.69 per share. | 03 Jun 2025 | 75 | 1,708 (0%) | 0% | 3.7 | 277 | Common Stock |
| Bionano Genomics Inc | R. Erik Holmlin | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2025 | 17,449 | 17,449 | - | - | Stock Option (Right to Buy) | |
| Bionano Genomics Inc | R. Erik Holmlin | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.47 per share. | 14 Mar 2025 | 198 | 1,783 (0%) | 0% | 3.5 | 687 | Common Stock |
| Bionano Genomics Inc | R. Erik Holmlin | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.73 per share. | 15 Feb 2025 | 51 | 1,981 (0%) | 0% | 5.7 | 292 | Common Stock |
| Bionano Genomics Inc | R. Erik Holmlin | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 204,000 | 204,000 | - | - | Stock Option (Right to Buy) | |
| Bionano Genomics Inc | R. Erik Holmlin | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 44,000 | 121,813 (0%) | 0% | 0 | Common Stock | |
| Bionano Genomics Inc | R. Erik Holmlin | Director, PRESIDENT AND CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.27 per share. | 15 Feb 2024 | 3,073 | 77,663 (0%) | 0% | 1.3 | 3,903 | Common Stock |
| Bionano Genomics Inc | R. Erik Holmlin | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 0.64 per share. | 16 May 2023 | 15,000 | 806,474 (2%) | 0% | 0.6 | 9,639 | Common Stock |
| Bionano Genomics Inc | R. Erik Holmlin | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.66 per share. | 12 May 2023 | 50,141 | 791,474 (2%) | 0% | 0.7 | 33,093 | Common Stock |
| Bionano Genomics Inc | R. Erik Holmlin | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2023 | 1,400,000 | 1,400,000 | - | - | Stock Option (Right to Buy) | |
| Bionano Genomics Inc | R. Erik Holmlin | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2023 | 300,000 | 841,615 (2%) | 0% | 0 | Common Stock | |
| Bionano Genomics Inc | R. Erik Holmlin | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.41 per share. | 12 May 2022 | 50,141 | 538,556 (1%) | 0% | 1.4 | 70,699 | Common Stock |
| Bionano Genomics Inc | R. Erik Holmlin | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 1,400,000 | 1,400,000 | - | - | Stock Option (Right to Buy) | |
| Bionano Genomics Inc | R. Erik Holmlin | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 3.99 per share. | 29 Nov 2021 | 2,675 | 4,875 (0%) | 0% | 4.0 | 10,673 | Common Stock |
| Bionano Genomics Inc | R. Erik Holmlin | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 3.98 per share. | 29 Nov 2021 | 2,200 | 2,200 (0%) | 0% | 4.0 | 8,767 | Common Stock |
| Bionano Genomics Inc | R. Erik Holmlin | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 3.98 per share. | 29 Nov 2021 | 150 | 5,025 (0%) | 0% | 4.0 | 597 | Common Stock |
| Bionano Genomics Inc | R. Erik Holmlin | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2021 | 290,000 | 585,191 (1%) | 0% | 0 | Common Stock | |
| Bionano Genomics Inc | R. Erik Holmlin | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2021 | 290,000 | 295,191 (0%) | 0% | 0 | Common Stock | |
| Bionano Genomics Inc | R. Erik Holmlin | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2021 | 775,000 | 775,000 | - | - | Stock Option (Right to Buy) |